$CYAN
CYANOTECH CORP Stock $cyan

$cyan Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000143774923018616 Filed on June 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$5.146M	$5.392M	$23.18M
YoY Change	-23.38%	-33.65%	-35.56%
Cost Of Revenue	$3.614M	$4.005M	$15.92M
YoY Change	-17.83%	-23.45%	-28.94%
Gross Profit	$1.532M	$1.387M	$7.259M
YoY Change	-33.91%	-52.07%	-46.49%
Gross Profit Margin	29.77%	25.72%	31.32%
Selling, General & Admin	$2.550M	$2.427M	$9.409M
YoY Change	2.12%	5.48%	-8.47%
% of Gross Profit	166.45%	174.98%	129.62%
Research & Development	$191.0K	$214.0K	$770.0K
YoY Change	-22.36%	-6.55%	8.15%
% of Gross Profit	12.47%	15.43%	10.61%
Depreciation & Amortization	$407.0K	$412.0K	$1.655M
YoY Change	-2.4%	3.78%	3.5%
% of Gross Profit	26.57%	29.7%	22.8%
Operating Expenses	$2.741M	$2.641M	$10.18M
YoY Change	-0.07%	4.39%	-7.4%
Operating Profit	-$1.209M	-$1.254M	-$2.920M
YoY Change	184.47%	-444.51%	-213.44%
Interest Expense	$160.0K	-$169.0K	$502.0K
YoY Change	263.64%	111.25%	28.06%
% of Operating Profit
Other Income/Expense, Net			-$502.0K
YoY Change			28.06%
Pretax Income	-$1.369M	-$1.423M	-$3.422M
YoY Change	191.9%	-601.06%	-256.83%
Income Tax	$0.00	$7.000K	$18.00K
% Of Pretax Income
Net Earnings	-$1.369M	-$1.430M	-$3.440M
YoY Change	190.04%	-616.25%	-259.7%
Net Earnings / Revenue	-26.6%	-26.52%	-14.84%
Basic Earnings Per Share	-$0.22		-$0.55
Diluted Earnings Per Share	-$0.22	-$0.23	-$0.55
COMMON SHARES
Basic Shares Outstanding	6.291M	6.272M	6.244M
Diluted Shares Outstanding	6.290M		6.244M

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$648.0K	$974.0K	$974.0K
YoY Change	-12.08%	-62.38%	-62.38%
Cash & Equivalents	$648.0K	$974.0K
Short-Term Investments
Other Short-Term Assets	$378.0K	$484.0K	$484.0K
YoY Change	-2.07%	-11.19%	-11.19%
Inventory	$10.51M	$10.71M	$10.71M
Prepaid Expenses
Receivables	$1.794M	$1.331M	$1.331M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.33M	$13.50M	$13.50M
YoY Change	-11.3%	-17.02%	-17.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.07M	$11.37M	$16.14M
YoY Change	-7.14%	-4.37%	3.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$85.00K	$90.00K	$90.00K
YoY Change	-10.53%	-17.43%	-17.43%
Total Long-Term Assets	$15.81M	$16.23M	$16.23M
YoY Change	0.72%	2.86%	2.86%
TOTAL ASSETS
Total Short-Term Assets	$13.33M	$13.50M	$13.50M
Total Long-Term Assets	$15.81M	$16.23M	$16.23M
Total Assets	$29.13M	$29.73M	$29.73M
YoY Change	-5.16%	-7.23%	-7.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.721M	$1.021M	$1.021M
YoY Change	-10.69%	-56.77%	-56.77%
Accrued Expenses	$821.0K	$1.101M	$1.584M
YoY Change	-38.59%	-22.03%	-12.24%
Deferred Revenue	$77.00K	$89.00K
YoY Change	-2.53%	-45.73%
Short-Term Debt	$2.520M	$2.040M	$2.040M
YoY Change
Long-Term Debt Due	$5.833M	$5.409M	$3.369M
YoY Change	1411.14%	1003.88%	587.55%
Total Short-Term Liabilities	$8.946M	$8.103M	$8.103M
YoY Change	119.64%	68.08%	68.08%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	-76.6%	-76.94%	-76.94%
Other Long-Term Liabilities	$0.00	$3.000K	$4.278M
YoY Change	-100.0%	-80.0%	25.79%
Total Long-Term Liabilities	$1.000M	$1.003M	$5.278M
YoY Change	-76.66%	-76.95%	-31.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.946M	$8.103M	$8.103M
Total Long-Term Liabilities	$1.000M	$1.003M	$5.278M
Total Liabilities	$14.09M	$13.38M	$13.38M
YoY Change	20.63%	6.55%	6.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.00M	-$17.63M
YoY Change	29.57%	24.24%
Common Stock	$126.0K	$125.0K
YoY Change	1.61%	0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.04M	$16.35M	$16.35M
YoY Change
Total Liabilities & Shareholders Equity	$29.13M	$29.73M	$29.73M
YoY Change	-5.16%	-7.23%	-7.23%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$1.369M	-$1.430M	-$3.440M
YoY Change	190.04%	-616.25%	-259.7%
Depreciation, Depletion And Amortization	$407.0K	$412.0K	$1.655M
YoY Change	-2.4%	3.78%	3.5%
Cash From Operating Activities	-$596.0K	$583.0K	-$2.100M
YoY Change	-54.12%	-43.67%	-188.27%
INVESTING ACTIVITIES
Capital Expenditures	$150.0K	$50.00K	$1.068M
YoY Change	-139.89%	-109.52%	-184.09%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$150.0K	-$50.00K	-$1.068M
YoY Change	-60.11%	-90.48%	-15.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$420.0K	-72.00K	$1.553M
YoY Change	-337.29%	-67.12%	-167.91%
NET CHANGE
Cash From Operating Activities	-$596.0K	583.0K	-$2.100M
Cash From Investing Activities	-$150.0K	-50.00K	-$1.068M
Cash From Financing Activities	$420.0K	-72.00K	$1.553M
Net Change In Cash	-$326.0K	461.0K	-$1.615M
YoY Change	-82.4%	58.42%	37.1%
FREE CASH FLOW
Cash From Operating Activities	-$596.0K	$583.0K	-$2.100M
Capital Expenditures	$150.0K	$50.00K	$1.068M
Free Cash Flow	-$746.0K	$533.0K	-$3.168M
YoY Change	-19.18%	-65.83%	-186.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	64000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6271971
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6271971
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6202223
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6202223
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	cyan	Purchase Obligation Agreement Term PurchaseObligationAgreementTerm	P10Y
CY2023Q1	cyan	Number Of Shareholder Approved Sharebased Compensation Plans NumberOfShareholderApprovedSharebasedCompensationPlans	2	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	0-14602
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1206026
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	73-4460 Queen Kaahumanu Highway, Suite 102
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kailua-Kona
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	HI
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	96740
CY2023	dei	City Area Code CityAreaCode	808
CY2023	dei	Local Phone Number LocalPhoneNumber	326-1353
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
CY2023	dei	Trading Symbol TradingSymbol	CYAN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	8128352.16	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6291086
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Newport Beach, California
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	974000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2589000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1331000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3664000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10707000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	9466000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	484000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	545000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	13496000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	16264000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11366000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11885000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4776000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3787000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	90000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109000	usd
CY2023Q1	us-gaap	Assets Assets	29728000	usd
CY2022Q1	us-gaap	Assets Assets	32045000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1021000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2362000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1101000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1412000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	89000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	164000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	393000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1540000	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q1	cyan	Lines Of Credit Related Party Current LinesOfCreditRelatedPartyCurrent	500000	usd
CY2022Q1	cyan	Lines Of Credit Related Party Current LinesOfCreditRelatedPartyCurrent	0	usd
CY2023Q1	cyan	Longterm Debt Current Maturities Excluding Line Of Credit Current LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent	3369000	usd
CY2022Q1	cyan	Longterm Debt Current Maturities Excluding Line Of Credit Current LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent	490000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8103000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4821000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4336000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4275000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3386000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	13381000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	12558000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	125000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	124000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33856000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33557000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17634000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14194000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16347000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	19487000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29728000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32045000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23178000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35968000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32345000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15919000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22402000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21228000	usd
CY2023	us-gaap	Gross Profit GrossProfit	7259000	usd
CY2022	us-gaap	Gross Profit GrossProfit	13566000	usd
CY2021	us-gaap	Gross Profit GrossProfit	11117000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4659000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5367000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4876000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4750000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4913000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5518000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	770000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	712000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	639000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	10179000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10992000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	11033000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2920000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2574000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	84000	usd
CY2023	us-gaap	Interest Expense InterestExpense	502000	usd
CY2022	us-gaap	Interest Expense InterestExpense	392000	usd
CY2021	us-gaap	Interest Expense InterestExpense	550000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1389000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-502000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-392000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	839000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3422000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2182000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	923000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3440000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2154000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	920000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6244000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6157000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6070000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6244000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6168000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6079000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	15846000	usd
CY2021	cyan	Stock Issued During Period Value Director Stockgrants StockIssuedDuringPeriodValueDirectorStockgrants	158000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	68000	usd
CY2021	cyan	Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive	-0	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-7000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	920000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	17041000	usd
CY2022	cyan	Stock Issued During Period Value Director Stockgrants StockIssuedDuringPeriodValueDirectorStockgrants	158000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-52000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	186000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2154000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	19487000	usd
CY2023	cyan	Stock Issued During Period Value Director Stockgrants StockIssuedDuringPeriodValueDirectorStockgrants	158000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-10000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	152000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3440000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	16347000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3440000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2154000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	920000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1655000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1599000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1748000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1389000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	21000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	64000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	40000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	57000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	90000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	440000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	322000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	317000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	310000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	344000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	214000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	64000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	46000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2269000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1263000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	328000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1231000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	717000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1238000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	74000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-18000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1422000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-358000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-311000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	568000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-75000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-203000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-452000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-331000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-320000	usd
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-12000	usd
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-18000	usd
CY2021	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-22000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2100000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2379000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2400000	usd
CY2023	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1068000	usd
CY2022	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1270000	usd
CY2021	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	760000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1068000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1270000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-760000	usd
CY2023	cyan	Repayments Of Short Term Contractual Obligation RepaymentsOfShortTermContractualObligation	-0	usd
CY2022	cyan	Repayments Of Short Term Contractual Obligation RepaymentsOfShortTermContractualObligation	-0	usd
CY2021	cyan	Repayments Of Short Term Contractual Obligation RepaymentsOfShortTermContractualObligation	38000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1540000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1000000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1000000	usd
CY2023	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	500000	usd
CY2022	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	0	usd
CY2021	cyan	Proceeds From Lines Of Credit Related Parties ProceedsFromLinesOfCreditRelatedParties	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-500000	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	1381000	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	477000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	735000	usd
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	670000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	24000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	52000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7000	usd
CY2023	cyan	Proceeds From Issuance Of Common Stock And Stock Options Exercised ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised	0	usd
CY2022	cyan	Proceeds From Issuance Of Common Stock And Stock Options Exercised ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised	0	usd
CY2021	cyan	Proceeds From Issuance Of Common Stock And Stock Options Exercised ProceedsFromIssuanceOfCommonStockAndStockOptionsExercised	68000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1553000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2287000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-290000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1615000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1178000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1350000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2589000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3767000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2417000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	974000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2589000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3767000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	408000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	342000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	446000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	32000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	974000	usd
CY2023Q1	cyan	Working Capital Deficit WorkingCapitalDeficit	5393000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2589000	usd
CY2022Q1	cyan	Working Capital Deficit WorkingCapitalDeficit	11443000	usd
CY2023Q1	cyan	Long Term Debt And Capital Lease Obligations Current And Noncurrent LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent	3461000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported. Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary. Actual results could differ from those estimates and assumptions.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Concentration Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Company maintains its cash accounts in banks located in Hawaii, which are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to <em style="font: inherit;">$250,000</em> per bank. The Company had cash balances at <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022</em> that exceeded the balance insured by the FDIC by $422,000 and $2,089,000, respectively. A significant portion of revenues and accounts receivables are derived from a few major customers. For the year ended <em style="font: inherit;"> March 31, 2023, </em><span style="-sec-ix-hidden:c99198980"><span style="-sec-ix-hidden:c99199096">two</span></span> customers individually accounted for 34% and 6% of the Company’s total net sales and for the year ended <em style="font: inherit;"> March 31, 2022, </em><span style="-sec-ix-hidden:c99198991"><span style="-sec-ix-hidden:c99199097">two</span></span> customers individually accounted for 22% and 19% of the Company’s total net sales. Two customers accounted for 46% and 63% of the Company’s accounts receivable balance as of <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022,</em> respectively.</p>
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	422000	usd
CY2022Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2089000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	94000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	55000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	1513000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	1458000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2116000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1887000	usd
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1490000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2049000	usd
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2868000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6502000	usd
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4595000	usd
CY2023Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	269000	usd
CY2022Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	513000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10707000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	9466000	usd
CY2023	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	90000	usd
CY2022	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	0	usd
CY2021	cyan	Inventory Abnormal Production Costs InventoryAbnormalProductionCosts	110000	usd
CY2023	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	269000	usd
CY2022	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	136000	usd
CY2021	cyan	Non Inventoriable Fixed Costs NonInventoriableFixedCosts	179000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37094000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35376000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25947000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24339000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	219000	usd
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	848000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11366000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11885000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	21000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	64000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1655000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1599000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1748000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	5409000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	490000	usd
CY2023Q1	cyan	Longterm Debt Gross Excluding Current Maturities LongtermDebtGrossExcludingCurrentMaturities	1000000	usd
CY2022Q1	cyan	Longterm Debt Gross Excluding Current Maturities LongtermDebtGrossExcludingCurrentMaturities	4448000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	-0	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	112000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4336000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	92000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	112000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3461000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1000000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	4461000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	143000	usd
CY2022Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	488000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	215000	usd
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	211000	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	393000	usd
CY2022Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	392000	usd
CY2023Q1	cyan	Accrued Rent And Utilities Current AccruedRentAndUtilitiesCurrent	30000	usd
CY2022Q1	cyan	Accrued Rent And Utilities Current AccruedRentAndUtilitiesCurrent	108000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	320000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	213000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1101000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1412000	usd
CY2023	cyan	Operating Leases Expense Contingent Rentals OperatingLeasesExpenseContingentRentals	0	usd
CY2022	cyan	Operating Leases Expense Contingent Rentals OperatingLeasesExpenseContingentRentals	73000	usd
CY2021	cyan	Operating Leases Expense Contingent Rentals OperatingLeasesExpenseContingentRentals	50000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y9M18D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	719000	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y2M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.072	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	603000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1429000	usd
CY2023Q1	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	6149000	usd
CY2022Q1	cyan	Operating Lease Rightofuse Asset Before Accumulated Amortization OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization	4720000	usd
CY2023Q1	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	1373000	usd
CY2022Q1	cyan	Operating Lease Rightofuse Asset Accumulated Amortization OperatingLeaseRightofuseAssetAccumulatedAmortization	933000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4776000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3787000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	393000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4275000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3386000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4758000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3779000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	810000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	820000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	797000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	798000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	683000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2760000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6668000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1910000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4758000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	506000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	713000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	616000	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	822000	usd
CY2022Q1	us-gaap	Purchase Obligation PurchaseObligation	1105000	usd
CY2021Q1	us-gaap	Purchase Obligation PurchaseObligation	1005000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1950000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1104643
CY2023Q1	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Shares Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding	323334
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	318300
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.08
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	130000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.35
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	19000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.59
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	55000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.13
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	374300
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	129700	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.96
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.21
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	166800
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.84
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	252500
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.34
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	159650	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.43
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	49500
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.80
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	111333
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.90
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	us-gaap	Share Price SharePrice	0.88
CY2022Q1	us-gaap	Share Price SharePrice	3.37
CY2021Q1	us-gaap	Share Price SharePrice	3.30
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	141667
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.33
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.94
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	50000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	1.33
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	141667
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.55
CY2023	cyan	Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted	97000	usd
CY2022	cyan	Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted	80000	usd
CY2021	cyan	Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted	155000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	67000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	40000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	6000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	253000
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y6M
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	2.88
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	111333
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	2.90
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.94
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.60
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.20
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5747	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5823	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5444	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0336	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0106	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0040	pure
CY2023	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod	P3Y
CY2022	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod	P3Y
CY2021	cyan	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Vesting Period SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsVestingPeriod	P3Y
CY2023	cyan	Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.19	pure
CY2022	cyan	Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2021	cyan	Shareased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M12D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	cyan	Sharesauthorized Sharesauthorized	60000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3440000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6244000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2154000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6157000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11000
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	2154000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6168000
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2021	us-gaap	Net Income Loss NetIncomeLoss	920000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6070000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2021	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8000
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	920000	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6079000
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23178000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35968000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32345000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	28000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-952000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	591000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	263000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	23000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	16000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	11000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	518000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-557000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	12000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1000	usd
CY2023	cyan	Effective Income Tax Rate Reconciliation Expired Losses Amount EffectiveIncomeTaxRateReconciliationExpiredLossesAmount	380000	usd
CY2022	cyan	Effective Income Tax Rate Reconciliation Expired Losses Amount EffectiveIncomeTaxRateReconciliationExpiredLossesAmount	-0	usd
CY2021	cyan	Effective Income Tax Rate Reconciliation Expired Losses Amount EffectiveIncomeTaxRateReconciliationExpiredLossesAmount	-0	usd
CY2023	cyan	Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount	-24000	usd
CY2022	cyan	Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount	34000	usd
CY2021	cyan	Effective Income Tax Rate Reconciliation Deferred Tax Trueup Amount EffectiveIncomeTaxRateReconciliationDeferredTaxTrueupAmount	27000	usd
CY2023	cyan	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount	0	usd
CY2022	cyan	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount	0	usd
CY2021	cyan	Effective Income Tax Rate Reconciliation Ppp Loan Forgiveness Amount EffectiveIncomeTaxRateReconciliationPppLoanForgivenessAmount	298000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	13000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	38000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3570000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3140000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	50000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	175000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	177000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	251000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	28000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	28000	usd
CY2023Q1	cyan	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	108000	usd
CY2022Q1	cyan	Deferred Tax Assets Interest Limitation DeferredTaxAssetsInterestLimitation	0	usd
CY2023Q1	cyan	Deferred Tax Assets Operating Lease Right Of Use Assets DeferredTaxAssetsOperatingLeaseRightOfUseAssets	1323000	usd
CY2022Q1	cyan	Deferred Tax Assets Operating Lease Right Of Use Assets DeferredTaxAssetsOperatingLeaseRightOfUseAssets	1025000	usd
CY2023Q1	cyan	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	118000	usd
CY2022Q1	cyan	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	27000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5400000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4646000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2990000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2473000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2410000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2173000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1328000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1027000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1082000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1146000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2410000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2173000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14053000	usd
CY2023	dei	Auditor Firm AuditorFirmId	248

Files In Submission

Name	View Source	Status
0001437749-23-018616-index-headers.html	Edgar Link	pending
0001437749-23-018616-index.html	Edgar Link	pending
0001437749-23-018616.txt	Edgar Link	pending
0001437749-23-018616-xbrl.zip	Edgar Link	pending
cyan-20230331.xsd	Edgar Link	pending
cyan20230331_10k.htm	Edgar Link	pending
ex_528959.htm	Edgar Link	pending
ex_528960.htm	Edgar Link	pending
ex_528961.htm	Edgar Link	pending
ex_528962.htm	Edgar Link	pending
ex_528963.htm	Edgar Link	pending
ex_528964.htm	Edgar Link	pending
ex_528964img001.jpg	Edgar Link	pending
ex_528964img002.jpg	Edgar Link	pending
ex_528964img003.jpg	Edgar Link	pending
ex_528964img004.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
cyan-20230331_def.xml	Edgar Link	unprocessable
cyan-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cyan20230331_10k_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cyan-20230331_cal.xml	Edgar Link	unprocessable
cyan-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYAN
CYANOTECH CORP Stock $cyan

2023 Q2 Form 10-K Financial Statement

#000143774923018616 Filed on June 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN CYANOTECH CORP Stock $cyan

2023 Q2 Form 10-K Financial Statement

#000143774923018616 Filed on June 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYAN
CYANOTECH CORP Stock $cyan